RVX vs. AEZS, LTY, GSD, HEM, ACST, REUN, NEPT, ATE, SBM, and IMV
Should you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Aeterna Zentaris (AEZS), Liberty Biopharma (LTY), Devonian Health Group (GSD), Hemostemix (HEM), Acasti Pharma (ACST), Reunion Neuroscience (REUN), Neptune Wellness Solutions (NEPT), Antibe Therapeutics (ATE), Sirona Biochem (SBM), and IMV (IMV). These companies are all part of the "biotechnology" industry.
Resverlogix vs. Its Competitors
Aeterna Zentaris (TSE:AEZS) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, community ranking, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.
Resverlogix's return on equity of 6.06% beat Aeterna Zentaris' return on equity.
Resverlogix received 302 more outperform votes than Aeterna Zentaris when rated by MarketBeat users. However, 88.89% of users gave Aeterna Zentaris an outperform vote while only 84.01% of users gave Resverlogix an outperform vote.
Resverlogix has lower revenue, but higher earnings than Aeterna Zentaris. Resverlogix is trading at a lower price-to-earnings ratio than Aeterna Zentaris, indicating that it is currently the more affordable of the two stocks.
In the previous week, Aeterna Zentaris' average media sentiment score of 0.00 equaled Resverlogix'saverage media sentiment score.
Aeterna Zentaris has a beta of 2.26, meaning that its stock price is 126% more volatile than the S&P 500. Comparatively, Resverlogix has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
5.2% of Aeterna Zentaris shares are held by institutional investors. 1.3% of Aeterna Zentaris shares are held by insiders. Comparatively, 42.7% of Resverlogix shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Resverlogix beats Aeterna Zentaris on 6 of the 11 factors compared between the two stocks.
Get Resverlogix News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Resverlogix Competitors List
Related Companies and Tools
This page (TSE:RVX) was last updated on 6/24/2025 by MarketBeat.com Staff
Buy RVX Stock Free RVX Stock Alerts